VistaGen Therapeutics, Inc. (VTGN) — Analyst estimates
Consensus analyst estimates for VistaGen Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 500K | -0.37 | 1 |
| 2027 | 198.15K | -0.41 | 1 |
Consensus analyst estimates by fiscal year.